Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Streetwise Reports
$12.00
Provider: Streetwise Reports
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

MusclePharm Corp Reaffirms FY 2013 Revenue Guidance


Wednesday, 15 May 2013 04:05pm EDT 

MusclePharm Corp announced that for fiscal 2013, it remains on track to meet previous guidance for gross revenue to exceed $100 million. 

Company Quote

12.14
0.04 +0.33%
22 Aug 2014